Molbio IPO：投资者是否应该申购？
· thehindubusinessline.com
Molbio 的 IPO 为投资者提供了增长机会，但在激烈的市场竞争中，高估值可能会带来风险。
Molbio is a point-of-care technology (POCT) diagnostics company whose IPO is open from August 10-12. The company developed Truenat, a POCT polymerase chain reac...